5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain
US-9180122-B2 · Nov 10, 2015 · US
Hazel Katherine was listed as an assignee on 2 patent publications in 2015.
| Metric | Value |
|---|---|
| Company | Hazel Katherine |
| Year | 2015 |
| Patents | 2 |
Representative publications for Hazel Katherine in 2015.
Most common classification codes for Hazel Katherine in 2015.
Navigate to parent entity pages.